Status of the Endangered Indian Knob Mountainbalm Eriodictyon altissimum (Namaceae) in Central Coastal California

Indian Knob Mountainbalm Eriodictyon altissimum (Namaceae) is a shrub endemic to western San Luis Obispo County in central coastal California, and little has been published regarding it. The species was listed as endangered under the California Endangered Species Act in 1979 and the U.S. Endangered Species Act in 1995. At Federal listing in 1995, Indian Knob mountainbalm was known from six occurrences, two of which were in protected areas, with a total population estimate of 2018, Indian Knob mountainbalm is known from seven occurrences, six of which are in protected areas and one (the largest) mostly in a protected area, with a total population count of 6,489+ individuals in 2016. Two occurrences are likely extirpated. Indian Knob mountainbalm is considered a fire-adapted chaparral plant. Reproduction is reported to be primarily vegetative by underground rhizomes, and it is specialized for substrates with physical disturbances, including: steep rocky slopes, cliff faces, fallen rock debris, sand dunes (shifting sand), roadsides, old graded substrates such as dirt/rock roads, the talus of graded substrates, and trails. We report the species grows up to 5.5 m tall and at 98 to 263 m elevation. In consideration of the life history traits used by Anacker et al. (2013) for rare plants in California, Indian Knob mountainbalm would be considered highly vulnerable to climate change. Using the international standards of IUCN, Indian Knob mountainbalm meets the criteria for classification as critically endangered including the following: geographic range, severely fragmented; extent of occurrence, 34 km2 (km2); area of occupancy, 2 (km2); and quality of habitat, continuing to decline (dense vegetation, lack of recent fire). Coordinated conservation and research are needed to further understand the species, and to restore and maintain the five extant occurrences

Ramucirumab plus docetaxel versus placebo plus docetaxel in patients with locally advanced or metastatic urothelial carcinoma after platinum-based therapy (RANGE): a randomised, double-blind, phase 3 trial

Few treatments with a distinct mechanism of action are available for patients with platinum-refractory advanced or metastatic urothelial carcinoma. We assessed the efficacy and safety of treatment with docetaxel plus either ramucirumab-a human IgG1 VEGFR-2 antagonist-or placebo in this patient population

Treatment of personality pathology through the lens of the hierarchical taxonomy of psychopathology: Developing a research agenda.

Despite the emphasis on evidence-based treatment for psychological disorders, to date, there has been limited research examining treatment for nine of the 10 categorical personality disorders in DSM-5 Section 2. This is perhaps not surprising given the complex heterogeneity and co-morbidity within personality pathology. The hierarchical taxonomy of psychopathology (HiTOP) was proposed to address limitations within the traditional categorical model of the diagnostic system. Within this system are five spectra: detachment, antagonistic externalizing, disinhibited externalizing, thought disorder and internalizing. These foundational personality traits potentially have direct and specific treatment implications. The purpose of this paper is to highlight potential psychotherapeutic and pharmacological treatment recommendations within the personality spectra. Additionally, we outline the advantages of considering the personality science found within dimensional models of psychopathology in clinical assessment and intervention to aid in treatment planning. © 2019 John Wiley & Sons, Ltd

Treatment of personality pathology through the lens of the hierarchical taxonomy of psychopathology: Developing a research agenda

Despite the emphasis on evidence-based treatment for psychological disorders, to date, there has been limited research examining treatment for nine of the 10 categorical personality disorders in DSM-5 Section 2. This is perhaps not surprising given the complex heterogeneity and co-morbidity within personality pathology. The hierarchical taxonomy of psychopathology (HiTOP) was proposed to address limitations within the traditional categorical model of the diagnostic system. Within this system are five spectra: detachment, antagonistic externalizing, disinhibited externalizing, thought disorder and internalizing. These foundational personality traits potentially have direct and specific treatment implications. The purpose of this paper is to highlight potential psychotherapeutic and pharmacological treatment recommendations within the personality spectra. Additionally, we outline the advantages of considering the personality science found within dimensional models of psychopathology in clinical assessment and intervention to aid in treatment planning